Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 84 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 7713973

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 11, 2010 · Expires May 6, 2030

    granted
  2. US 7709482

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  3. US 7709190

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  4. US 7705164

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted
  5. US 7700609

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  6. US 7696227

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  7. US 7696218

    Substituted 1,3-dialkyl-2,4-dioxo-6-(arylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Takeda San Diego, Inc. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  8. US 7691885

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  9. US 7691853

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  10. US 7687506

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  11. US 7687625

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  12. US 7687660

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  13. US 7687638

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  14. US 7687459

    Arylalkoxyl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  15. US 7683033

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  16. US 7666647

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  17. US 7662779

    Triazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  18. US 7662999

    Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  19. US 7662814

    4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors

    Laboratories Almirall, S.A. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  20. US 7662910

    Inhibitors for the soluble epoxide hydrolase

    The Regents of the University of California · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  21. US 7659283

    Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  22. US 7652153

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted
  23. US 7652135

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted
  24. US 7649115

    MAO-B inhibitors useful for treating obesity

    Jenrin Discovery, LLC · Granted Jan 19, 2010 · Expires Jan 14, 2030

    granted